New Randomized Trial Shows ReCell® Heals Donor Sites Faster

VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England–(BUSINESS WIRE)–Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical (ASX:AVH) (OTCQX:AVMXY), said today. Avita, a regenerative medicine company focused on the treatment of wounds and skin defects, said the fi
Source: BusinessWire-Primary

New Randomized Trial Shows ReCell® Heals Donor Sites Faster